Global Analgesics Market, By Drug Class, By Indication, By Dosage Form, By Drug Composition, By Availability, By Type, By Gender, By Age Group, By Route of Administration, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia P
Description
Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.
Market Dynamics:
Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.
Key Features of the Study:
- This report provides in-depth analysis of the global analgesics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global analgesics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market
Detailed Segmentation
Market Dynamics:
Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.
Key Features of the Study:
- This report provides in-depth analysis of the global analgesics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global analgesics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market
Detailed Segmentation
- By Drug Class
- Analgesic Combinations (Includes Narcotic Analgesic Combinations)
- Acetaminophen + Aspirin
- Acetaminophen + Aspirin + Caffeine
- Acetaminophen + Butalbital
- Acetaminophen + Butalbital + Caffeine
- Acetaminophen + Caffeine
- Acetaminophen +Caffeine + Isometheptene Mucate
- Acetaminophen + Caffeine + Magnesium Salicylate
- Acetaminophen + Diphenhydramine
- Aspirin + Butalbital + Caffeine
- Codeine + Acetaminophen
- Codeine + Acetaminophen + Butalbital + Caffeine
- Codeine + Aspirin + Butalbital + Caffeine
- Dihydrocodeine + Acetaminophen + Caffeine
- Hydrocodone + Acetaminophen
- Hydrocodone + Ibuprofen
- Ibuprofen + Diphenhydramine
- Naproxen + Diphenhydramine
- Oxycodone + Acetaminophen
- Tramadol + Acetaminophen
- Antimigraine Agents
- Almotriptan
- Dihydroergotamine Nasal
- Eletriptan
- Ergotamine
- Ergotamine + Caffeine
- Frovatriptan
- Naratriptan
- Rizatriptan
- Sumatriptan Injection
- Sumatriptan + Naproxen
- Zolmitriptan
- Cox-2 Inhibitors (Celecoxib)
- Acetaminophen and Miscellaneous Analgesics
- Acetaminophen
- Ziconotide
- Narcotic Analgesics
- Alfentanil
- Buprenorphine
- Butorphanol (Injection)
- Codeine
- Fentanyl
- Hydrocodone
- Hydromorphone
- Levorphanol
- Meperidine
- Methadone
- Morphine
- Nalbuphine
- Oxycodone
- Oxymorphone
- Tramadol
- Tapentadol
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- More COX-1 selective
- Flurbiprofen
- Ketorolac (nasal)
- Ketoprofen
- Tolmetin
- Relatively nonselective
- Ibuprofen
- Naproxen
- Less than 50-fold COX-2 selective
- Indomethacin
- Sulindac
- Piroxicam
- Mefenamic acid
- Meloxicam
- Diclofenac
- Celecoxib
- Etodolac
- Salicylates
- Aspirin
- Diflunisal
- Magnesium salicylate
- Salsalate
- CGRP inhibitors
- Erenumab
- Galcanezumab
- Fremanezumab
- Rimegepant
- Ubrogepant
- Atogepant
- Eptinezumab
- Zavegepant
- By Indication
- Migraine
- Chronic Migraine
- Migraine Prevention
- Headache and Cluster Headaches
- Allergic Rhinitis
- Anxiety
- Back Pain
- Cold Symptoms
- Fever
- Hangover
- Influenza
- Insomnia
- Muscle Pain
- Osteoarthritis
- Pain
- Pain/Fever
- Period Pain
- Postoperative Pain
- Premenstrual Dysphoric Disorder
- Premenstrual Syndrome
- Rheumatoid Arthritis
- Sinusitis
- Ankylosing Spondylitis
- Chronic Pain
- Familial Adenomatous Polyposis
- High Blood Pressure
- Juvenile Rheumatoid Arthritis
- Spondylarthritis
- Chiari Malformation
- Eustachian Tube Dysfunction
- Neck Pain
- Plantar Fasciitis
- Sciatica
- Transverse Myelitis
- Cough
- Opioid Use Disorder
- Aseptic Necrosis
- Bartter Syndrome
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Diffuse Idiopathic Skeletal Hyperostosis
- Dysautonomia
- Frozen Shoulder
- Gout, Acute
- Inflammatory Conditions
- NSAID-Induced Ulcer Prophylaxis
- Patent Ductus Arteriosus
- Polyarticular Juvenile Idiopathic Arthritis
- Polymyalgia Rheumatica
- Radiculopathy
- Spondylolisthesis
- Temporomandibular Joint Disorder
- Tendonitis
- Toothache
- Anesthetic Adjunct
- Breakthrough Pain
- Diabetic Peripheral Neuropathy
- Diarrhea
- Labor Pain
- Light Sedation
- Neonatal Abstinence Syndrome
- Opiate Dependence - Induction
- Opiate Dependence - Maintenance
- Opiate Withdrawal
- Sedation
- Angina
- Angina Pectoris Prophylaxis
- Antiphospholipid Syndrome
- Gas
- Heart Attack
- Indigestion
- Ischemic Stroke
- Ischemic Stroke, Prophylaxis
- Kawasaki Disease
- Lupus
- Myocardial Infarction, Prophylaxis
- Niacin Flush
- Prevention of Thromboembolism in Atrial Fibrillation
- Prosthetic Heart Valves - Thrombosis Prophylaxis
- Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis
- Revascularization Procedures, Prophylaxis
- Rheumatic Fever
- Thromboembolic Stroke Prophylaxis
- Transient Ischemic Attack
- Others
- By Dosage Form
- Tablet
- Capsule
- Injectable
- Patches
- Roll On
- Spray
- Creams, Gels and Ointments
- Others (Suppository, Nasal etc.)
- By Drug Composition
- Single
- Combination
- By Availability
- OTC
- Rx
- By Type
- Branded
- Generics
- By Gender
- Male
- Female
- By Age Group
- Pedatric/Infant
- Children
- Adult
- Geriatrics
- By Route of Administration
- Oral/Enteral
- Parenteral
- Topical (Including Patches)
- Others (Rectal, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Reddy’s Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin
Table of Contents
170 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Dosage Form
- Market Snapshot, By Drug Composition
- Market Snapshot, By Availability
- Market Snapshot, By Type
- Market Snapshot, By Gender
- Market Snapshot, By Age Group
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
- 4. Global Analgesics Market, By Drug Class, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Analgesic Combinations (includes Narcotic Analgesic Combinations)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Acetaminophen + Aspirin
- Acetaminophen + Aspirin + Caffeine
- Acetaminophen + Butalbital
- Acetaminophen + Butalbital + Caffeine
- Acetaminophen + Caffeine
- Acetaminophen +Caffeine + Isometheptene Muscat
- Acetaminophen + Caffeine + Magnesium Salicylate
- Acetaminophen + Diphenhydramine
- Aspirin + Butalbital + Caffeine
- Codeine + Acetaminophen
- Codeine + Acetaminophen + Butalbital + Caffeine
- Codeine + Aspirin + Butalbital + Caffeine
- Dihydrocodeine + Acetaminophen + Caffeine
- Hydrocodone + Acetaminophen
- Hydrocodone + Ibuprofen
- Ibuprofen + Diphenhydramine
- Naproxen + Diphenhydramine
- Oxycodone + Acetaminophen
- Tramadol + Acetaminophen
- Antimigraine Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Almotriptan
- Dihydroergotamine Nasal
- Eletriptan
- Ergotamine
- Ergotamine + Caffeine
- Frovatriptan
- Naratriptan
- Rizatriptan
- Sumatriptan Injection
- Sumatriptan + Naproxen
- Zolmitriptan
- Compound Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Acetaminophen and Miscellaneous Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Acetaminophen
- Ziconotide
- Narcotic Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Alfentanil
- Buprenorphine
- Butorphanol (Injection)
- Codeine
- Fentanyl
- Hydrocodone
- Hydromorphone
- Levorphanol
- Meperidine
- Methadone
- Morphine
- Nalbuphine
- Oxycodone
- Oxymorphone
- Tramadol
- Tapentadol
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Codeine More COX-1 selective
- Flurbiprofen
- Ketorolac (nasal)
- Ketoprofen
- Tolmetin
- Relatively nonselective
- Ibuprofen
- Naproxen
- Less than 50-fold COX-2 selective
- Indomethacin
- Sulindac
- Piroxicam
- Mefenamic acid
- Meloxicam
- Diclofenac
- Celecoxib
- Etodolac
- Salicylates
- Aspirin
- Diflunisal
- Magnesium salicylate
- Salsalate
- CGRP inhibitors
- Erenumab
- Galcanezumab
- Fremanezumab
- Rimegepant
- Ubrogepant
- Atogepant
- Eptinezumab
- Zavegepant
- 5. Global Analgesics Market, By Indication, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Migraine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Chronic Migraine
- Migraine Prevention
- Headache and Cluster Headaches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Allergic Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Anxiety
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Back Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Cold Symptoms
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Hangover
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Insomnia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Muscle Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Pain/Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Period Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Postoperative Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Premenstrual Dysphoric Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Premenstrual Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Sinusitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Ankylosing Spondylitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Chronic Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Familial Adenomatous Polyposis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- High Blood pressure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Juvenile Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Spondylarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Chiari Malformation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Eustachian Tube Dysfunction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Neck Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Plantar Fasciitic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Sciatica
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Transverse Myelitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Cough
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Opioid Use Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Aseptic Necrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Bartter Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Bursitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Chronic Myofacial Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Costochondritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Diffuse Idiopathic Skeletal Hyperostosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Dysautonomia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Frozen Shoulder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Gout, Acute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Inflammatory Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- NSAID-Induced Ulcer Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Patent Ductus Arteriosus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Polymyalgia Rheumatica
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Radiculopathy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Spondylolisthesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Temporomandibular Joint Disorder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Tendonitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Toothache
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Aesthetic Adjunct
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Breakthrough Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Diabetic Peripheral Neuropathy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Diarrhea
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Labor Pain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Light Sedation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Neonatal Abstinence Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Opiate Dependence - Induction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Opiate Dependence – Maintenance
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Opiate Withdrawal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Sediation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Angina
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Angina Pectoris Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Antiphospholipid Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Gas
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Heart Attack
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Indigestion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Ischemic Stroke
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Ischemic Stroke, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Niacin Flush
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Myocardial Infraction, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Niacin Flush
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Prevention of Thromboesmbolism in Atrial Fibrillation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Prosthetic Heart Valves- Thrombosis Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Prosthetic Heart Valves, Mechanical Valves – Thrombosis Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Revascularization Procedure, Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Rheumatic Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Thromboembolic Stroke Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Transient Ischemic Attack
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 6. Global Analgesics Market, By Dosage Form, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Tabel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Roll On
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Creams, Gels, and Ointments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Others (Suppository, Nasal etc)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 7. Global Analgesics Market, By Drug Composition, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Single
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Combination
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 8. Global Analgesics Market, By Availability, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- OTC
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Rx
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 9. Global Analgesics Market, By Type, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 10. Global Analgesics Market, By Gender, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 11. Global Analgesics Market, By Age Group, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Pedatric/Infant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Children
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Adult
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 12. Global Analgesics Market, By Distribution Channel, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 13. Global Analgesics Market, By Age Group, 2020 – 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 – 2032
- Segment Trends
- Pedatric/Infant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Children
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- Adult
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
- 14. Global Analgesics Market, By Region, 2020 – 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
- 15. Competitive Landscape
- Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy’s Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 17. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
